NVOH vs. DBAW
NVOH (Novo Nordisk A/S (B Shares) ADRhedged ETF) and DBAW (Xtrackers MSCI All World ex US Hedged Equity ETF) are both Foreign Large Cap Equities funds. NVOH is actively managed, while DBAW is passively managed. Over the past year, NVOH returned -32.94% vs 39.95% for DBAW. At a 0.30 correlation, their price movements are largely independent. NVOH charges 0.19%/yr vs 0.41%/yr for DBAW.
Performance
NVOH vs. DBAW - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NVOH achieves a -4.50% return, which is significantly lower than DBAW's 19.37% return.
NVOH
- 1D
- 6.82%
- 1M
- 3.96%
- YTD
- -4.50%
- 6M
- 1.36%
- 1Y
- -32.94%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
DBAW
- 1D
- 0.47%
- 1M
- 5.47%
- YTD
- 19.37%
- 6M
- 19.97%
- 1Y
- 39.95%
- 3Y*
- 22.59%
- 5Y*
- 12.02%
- 10Y*
- 12.30%
NVOH vs. DBAW - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
NVOH Novo Nordisk A/S (B Shares) ADRhedged ETF | -4.50% | -43.79% |
DBAW Xtrackers MSCI All World ex US Hedged Equity ETF | 19.37% | 24.85% |
Correlation
The correlation between NVOH and DBAW is 0.30, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.30 |
Correlation (All Time) Calculated using the full available price history since Jan 7, 2025 | 0.30 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NVOH vs. DBAW — Risk / Return Rank
NVOH
DBAW
NVOH vs. DBAW - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Novo Nordisk A/S (B Shares) ADRhedged ETF (NVOH) and Xtrackers MSCI All World ex US Hedged Equity ETF (DBAW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NVOH | DBAW | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.59 | ||
| Sortino ratioReturn per unit of downside risk | -4.61 | ||
| Omega ratioGain probability vs. loss probability | 0.90 | 1.57 | -0.67 |
| Calmar ratioReturn relative to maximum drawdown | -0.71 | 4.46 | -5.18 |
| Martin ratioReturn relative to average drawdown | -1.13 | 18.16 | -19.30 |
Loading charts...
Drawdowns
NVOH vs. DBAW - Drawdown Comparison
The maximum NVOH drawdown since its inception was -61.60%, which is greater than DBAW's maximum drawdown of -31.44%. Use the drawdown chart below to compare losses from any high point for NVOH and DBAW.
Loading charts...
Drawdown Indicators
| NVOH | DBAW | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -61.60% | -31.44% | -30.16% |
Max Drawdown (1Y)Largest decline over 1 year | -46.22% | -9.00% | -37.22% |
Max Drawdown (3Y)Largest decline over 3 years | — | -14.11% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -17.87% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -31.44% | — |
Current DrawdownCurrent decline from peak | -49.74% | 0.00% | -49.74% |
Average DrawdownAverage peak-to-trough decline | -38.69% | -4.98% | -33.71% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 32.05% | 2.21% | +29.84% |
Volatility
NVOH vs. DBAW - Volatility Comparison
Novo Nordisk A/S (B Shares) ADRhedged ETF (NVOH) has a higher volatility of 11.12% compared to Xtrackers MSCI All World ex US Hedged Equity ETF (DBAW) at 5.66%. This indicates that NVOH's price experiences larger fluctuations and is considered to be riskier than DBAW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NVOH | DBAW | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.12% | 5.66% | +5.46% |
Volatility (6M)Calculated over the trailing 6-month period | 36.84% | 12.02% | +24.82% |
Volatility (1Y)Calculated over the trailing 1-year period | 49.73% | 13.75% | +35.98% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 48.86% | 13.91% | +34.95% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 48.86% | 15.30% | +33.56% |
NVOH vs. DBAW - Expense Ratio Comparison
NVOH has a 0.19% expense ratio, which is lower than DBAW's 0.41% expense ratio.
Dividends
NVOH vs. DBAW - Dividend Comparison
NVOH's dividend yield for the trailing twelve months is around 6.77%, more than DBAW's 1.64% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
DBAW Xtrackers MSCI All World ex US Hedged Equity ETF | 1.64% | 3.83% | 1.70% | 3.45% | 8.81% | 2.05% | 2.08% | 2.91% | 2.93% | 2.41% | 1.99% | 5.74% |
NVOH Novo Nordisk A/S (B Shares) ADRhedged ETF | 6.77% | 2.38% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
NVOH and DBAW have a correlation of 0.30, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NVOH has higher volatility (11.12%) compared to DBAW (5.66%). In terms of maximum drawdown, NVOH dropped -61.60% vs DBAW's -31.44%.
On 1-year performance, DBAW leads with 39.95% vs -32.94% for NVOH. On fees, NVOH is cheaper at 0.19% per year. On volatility, DBAW has been the lower-risk option at 5.66%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, DBAW has performed better with a 39.95% return vs -32.94%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
NVOH is cheaper with a 0.19% expense ratio, compared with 0.41% for DBAW.
NVOH has the higher dividend yield at 6.77%, compared with 1.64% for DBAW.
They also come from different issuers: Precidian and Deutsche Bank. Their fees differ too: 0.19% for NVOH and 0.41% for DBAW.
DBAW currently has the higher Sharpe Ratio (2.92 vs -0.67), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NVOH and DBAW
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer